Close Menu

chlamydia

The CE mark is for two assays covering chlamydia, gonorrhea, and trichomonas, and which run on the BD Max system. 

Meridian received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.

According to the firm's CEO, the delay in launching the io system is due to a decision to automate parts of its platform, resulting in increased multiplexing.

The waiver opens up a significant new opportunity for Alere within the physician office market, according to a company executive.

Trends included expanding test menus and a possible tipping point for point-of-care.

NEW YORK (GenomeWeb) ― In the first update since 2007, the US Preventative Services Task Force recently provided new guidelines to clinicians for chlamydia and gonorrhea screening.

NEW YORK (GenomeWeb) — Becton Dickinson executives this week updated investors on its molecular diagnostics sales and development pipeline, and provided a window into the company's plans for GenCell, the next-generation sequencing sample prep firm it acquired last month.

NEW YORK (GenomeWeb) — Cepheid said last week that its third quarter revenues grew 15 percent year over year driven primarily by stronger than expected commercial clinical revenue resulting from new Xpert assays and customer types.

NEW YORK (GenomeWeb) — Bay Area startup Diassess has been awarded nearly $300,000 from the National Institutes of Health for the first year of a two-year project to develop a point-of-care, nucleic acid amplification-based diagnostic device for sexually transmitted infections, with an initial foc

NEW YORK (GenomeWeb) – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter inched up 1 percent year over year.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.